COST

940.67

+1.38%↑

PG

147.06

-0.53%↓

KO

68.67

+1%↑

PM

147.6

+2.11%↑

PEP

142.9

-0.45%↓

COST

940.67

+1.38%↑

PG

147.06

-0.53%↓

KO

68.67

+1%↑

PM

147.6

+2.11%↑

PEP

142.9

-0.45%↓

COST

940.67

+1.38%↑

PG

147.06

-0.53%↓

KO

68.67

+1%↑

PM

147.6

+2.11%↑

PEP

142.9

-0.45%↓

COST

940.67

+1.38%↑

PG

147.06

-0.53%↓

KO

68.67

+1%↑

PM

147.6

+2.11%↑

PEP

142.9

-0.45%↓

COST

940.67

+1.38%↑

PG

147.06

-0.53%↓

KO

68.67

+1%↑

PM

147.6

+2.11%↑

PEP

142.9

-0.45%↓

Search

Afya Ltd (Class A)

Cerrado

SectorConsumo defensivo

14.08 -0.14

Resumen

Variación precio

24h

Actual

Mínimo

13.64

Máximo

14.16

Métricas clave

By Trading Economics

Ingresos

-58M

194M

Ventas

-17M

919M

P/B

Media del Sector

10.021

29.307

Rentabilidad por dividendo

1.64

Margen de beneficio

21.102

EBITDA

-56M

425M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+53.08% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.64%

3.55%

Próximas Ganancias

12 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-49M

1.3B

Apertura anterior

14.22

Cierre anterior

14.08

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

67 / 148 Clasificación en Consumer defensive

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Afya Ltd (Class A) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 nov 2025, 23:57 UTC

Ganancias

Naver's Third-Quarter Earnings Rose on AI Push

4 nov 2025, 23:10 UTC

Adquisiciones, fusiones, absorciones

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4 nov 2025, 23:48 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 nov 2025, 23:48 UTC

Charlas de Mercado

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4 nov 2025, 23:37 UTC

Charlas de Mercado

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4 nov 2025, 23:30 UTC

Ganancias

Itau Unibanco 3Q Net BRL33.7B >ITUB

4 nov 2025, 23:25 UTC

Ganancias

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4 nov 2025, 23:25 UTC

Ganancias

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4 nov 2025, 23:24 UTC

Ganancias

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4 nov 2025, 23:23 UTC

Ganancias

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4 nov 2025, 23:06 UTC

Ganancias

Review & Preview: Tech Check -- Barrons.com

4 nov 2025, 22:52 UTC

Ganancias

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4 nov 2025, 22:33 UTC

Ganancias

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4 nov 2025, 22:29 UTC

Ganancias

Ashland 4Q Adj EPS $1.08 >ASH

4 nov 2025, 22:29 UTC

Ganancias

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4 nov 2025, 22:28 UTC

Ganancias

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4 nov 2025, 22:27 UTC

Ganancias

Ashland 4Q Cont Ops EPS 73c >ASH

4 nov 2025, 22:27 UTC

Ganancias

Ashland 4Q EPS 71c >ASH

4 nov 2025, 22:27 UTC

Ganancias

Ashland 4Q Sales $478M >ASH

4 nov 2025, 22:23 UTC

Ganancias

Ovintiv 3Q EPS 57c >OVV

4 nov 2025, 22:19 UTC

Charlas de Mercado

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4 nov 2025, 22:16 UTC

Ganancias

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4 nov 2025, 22:14 UTC

Adquisiciones, fusiones, absorciones

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4 nov 2025, 22:13 UTC

Adquisiciones, fusiones, absorciones

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4 nov 2025, 22:13 UTC

Adquisiciones, fusiones, absorciones

Consortium: Able to Finance a Deal With Available Liquidity

4 nov 2025, 22:12 UTC

Adquisiciones, fusiones, absorciones

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4 nov 2025, 22:11 UTC

Ganancias

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4 nov 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4 nov 2025, 22:10 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov 2025, 22:07 UTC

Ganancias

Kinross Gold Raises Dividend to $0.035 >K.T

Comparación entre iguales

Cambio de precio

Afya Ltd (Class A) Esperado

Precio Objetivo

By TipRanks

53.08% repunte

Estimación a 12 meses

Media 21.63 USD  53.08%

Máximo 25.5 USD

Mínimo 17.5 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Afya Ltd (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

18.968 / 19.56Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

67 / 148 Clasificación en Consumo defensivo

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat